Kabra Drugs Ltd.

View in App
7.19 ▼0%

29 April 2024, 04:01:00 PM

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kabradrugs.com
Market Cap 3.16 Cr.
Enterprise Value(EV) 4.75 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -1.16 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 42.21 Trailing Twelve Months Ending 2023-12
Book Value / Share -2.50 Trailing Twelve Months Ending 2023-12
Price to Book Value -2.88 Calculated using Price: 7.19
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.44 Cr. 4,388,600 Shares
FaceValue 10
About Kabra Drugs Ltd.
The company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products.

Kabra Drugs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Kabra Drugs Ltd. Performance

View details >>
1 Day
1 Week
1 Month
3 Month
+4.96%
6 Month
+27.03%
1 Year
+33.15%
2 Year
+123.99%
5 Year
+1098.33%
10 Year
-26.26%

Kabra Drugs Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 2.55 1.05 5.02 -171.4 -144.2 -2869.33 0 0 0
Return on Capital Employed (%) 3.52 5.81 7.49 -80.09 -19.67 -8.82 -27.33 -27.96 -52.6
Return on Assets (%) 0.79 0.31 1.67 -58.3 -10.36 -4.11 -12.78 -17.39 -47.15

Kabra Drugs Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 3 3 3 0 0 0 0 0 -1 -1
Non Curr. Liab. 3 2 1 0 0
Curr. Liab. 3 4 3 1 1 1 2 1 1 2
Minority Int.
Equity & Liab. 9 9 6 2 1 1 1 1 1 1
Non Curr. Assets 3 3 3 0 0 0 0 0 0 0
Curr. Assets 6 6 4 1 1 1 1 1 1 1
Misc. Exp. not W/O
Total Assets 9 9 6 2 1 1 1 1 1 1

Kabra Drugs Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 8 10 8 2
Other Income 0 0 0 0 0 0 0
Total Income 8 10 8 2 0 0 0
Total Expenditure -8 -9 -7 -3 0 0 0 0 0 -1
PBIDT 0 0 1 -1 0 0 0 0 0 -1
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0
Taxation 0 0 0
Exceptional Items -1
PAT 0 0 0 -2 0 0 0 0 0 -1
Adjusted EPS 0 0 0 -5 0 0 0 0 -1 -1

Kabra Drugs Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0 0 0
Cash Fr. Inv. 0 0 0 0 2 0 0
Cash Fr. Finan. 0 1 0 0 -1 0 0 0 0
Net Change 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0

Kabra Drugs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Public 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Kabra Drugs Ltd. Announcements

View details >>
Tue, 30 Apr 2024
Regulation 40(9) & 40(10) Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended ('Listing Regulations')
Regulation 40(9) and 40(10) of SEBI LODR Regulations 2015
Thu, 11 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulation 2018
Mon, 08 Apr 2024
Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations 2015
Compliance Certificate Under Regulation 7(3) of SEBI (LODR) Regulations 2015

Kabra Drugs Ltd. Technical Scans

View details >>
Mon, 29 Apr 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at High Opening at High
Opening at Low Opening at Low

Kabra Drugs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,315.02 1,520.00 +1.2%
Cipla Ltd. 114,613.75 1,419.55 +1.3%
Divi's Laboratories Ltd. 105,233.07 3,956.05 -1.1%
Dr. Reddy's Laboratories Ltd. 104,900.33 6,260.00 +0.9%
Zydus Lifesciences Ltd. 99,425.98 988.00 +3.6%
Mankind Pharma Ltd. 93,499.34 2,340.20 -1.1%
Torrent Pharmaceuticals Ltd. 90,493.54 2,673.75 +1.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.91 1,520.00 +1.2%
Cipla Ltd. Consolidated 2023-12 30.91 1,419.55 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-12 76.09 3,956.05 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.06 6,260.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 33.43 988.00 +3.6%
Mankind Pharma Ltd. Consolidated 2023-12 54.14 2,340.20 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.57 2,673.75 +1.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.84 1,520.00 +1.2%
Cipla Ltd. Consolidated 2023-12 4.43 1,419.55 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-12 8.07 3,956.05 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.90 6,260.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.28 988.00 +3.6%
Mankind Pharma Ltd. Consolidated 2023-12 10.52 2,340.20 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.66 2,673.75 +1.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.00 +1.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,419.55 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,956.05 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,260.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 988.00 +3.6%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,340.20 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,673.75 +1.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.00 +1.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,419.55 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,956.05 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,260.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 988.00 +3.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,340.20 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,673.75 +1.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.00 +1.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,419.55 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,956.05 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,260.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 988.00 +3.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,340.20 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,673.75 +1.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.00 +1.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,419.55 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,956.05 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,260.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 988.00 +3.6%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,340.20 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,673.75 +1.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.00 +1.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,419.55 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,956.05 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,260.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 988.00 +3.6%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,340.20 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,673.75 +1.3%

Kabra Drugs Ltd. FAQ's

What is Kabra Drugs share price?
Can I buy Kabra Drugs shares now?
What is the Market Cap of Kabra Drugs?
What is the 52 Week High and Low of Kabra Drugs?